Literature DB >> 17531446

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).

Douglas J Biedenbach1, Jan M Bell, Helio S Sader, Thomas R Fritsche, Ronald N Jones, John D Turnidge.   

Abstract

Medical centres in eight countries in the Asia-Pacific region provided 2391 isolates for the SENTRY Antimicrobial Surveillance Program during 2003-2004 to determine their susceptibility to several antimicrobial classes, including daptomycin. Daptomycin, vancomycin and teicoplanin minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined for 120 isolates of Staphylococcus aureus, which included wild-type (WT) methicillin-resistant S. aureus (MRSA) and strains with decreased susceptibility to vancomycin (hetero-vancomycin-intermediate S. aureus (hVISA)). Oxacillin-resistant staphylococcal isolates were much less susceptible to the other tested agents compared with oxacillin-susceptible strains. Vancomycin resistance was higher among Enterococcus faecium (10.3%) than Enterococcus faecalis (0.4%), and macrolide resistance was high both for beta-haemolytic (17.7%) and viridans group (48.7%) streptococci. Daptomycin (MIC for 90% of the organisms (MIC(90))=0.5-1mg/L) was two-fold more potent than vancomycin, with >99% susceptibility when tested against staphylococci. All tested isolates of E. faecalis (MIC(90)=2mg/L) and beta-haemolytic streptococci (MIC(90)=0.5mg/L) were susceptible to daptomycin. Daptomycin MIC and MBC values were slightly higher for the hVISA isolates compared with WT-MRSA, with MBC/MIC ratios of only 1-2 for both groups. The MBC/MIC ratio for vancomycin was often greater when tested against these strains, particularly hVISA. In contrast, teicoplanin MBC/MIC ratios were significantly higher, with many of the strains showing values consistent with tolerance (>or=32). Daptomycin was demonstrated to have excellent in vitro activity when tested against Gram-positive isolates collected from Asia-Pacific countries, including hVISA strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531446     DOI: 10.1016/j.ijantimicag.2007.03.015

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.

Authors:  Maria M Traczewski; Bradley D Katz; Judith N Steenbergen; Steven D Brown
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

2.  Virulence determinants in vancomycin-resistant Enterococcus faecium vanA isolated from different sources at University Hospital of Londrina, Paraná, Brazil.

Authors:  Flávia Imanishi Ruzon; Suelen Balero de Paula; Renata Lumi Kanoshiki; Jussevania Pereira-Santos; Gilselena Kerbauy; Renata Katsuko Takayama Kobayashi; Lucy Megumi Yamauchi; Márcia Regina Eches Perugini; Sueli Fumie Yamada-Ogatta
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

3.  Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

Authors:  Julianne Kim; Sandra A N Walker; Dolores C Iaboni; Scott E Walker; Marion Elligsen; Michael S Dunn; Vanessa G Allen; Andrew Simor
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  Allison R McMullen; William Lainhart; Meghan A Wallace; Angela Shupe; Carey-Ann D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-24       Impact factor: 3.267

5.  Transfer of multidrug-resistant bacteria to healthcare workers' gloves and gowns after patient contact increases with environmental contamination.

Authors:  Daniel J Morgan; Elizabeth Rogawski; Kerri A Thom; J Kristie Johnson; Eli N Perencevich; Michelle Shardell; Surbhi Leekha; Anthony D Harris
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

Review 6.  Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.

Authors:  Bhavarth S Shukla; Timothy P Gauthier; Ricardo Correa; Laura Smith; Lilian Abbo
Journal:  Int J Clin Pharm       Date:  2013-07-27

7.  Surveillance on secular trends of incidence and mortality for device-associated infection in the intensive care unit setting at a tertiary medical center in Taiwan, 2000-2008: a retrospective observational study.

Authors:  Yin-Yin Chen; Liang-Yu Chen; Seng-Yi Lin; Pesus Chou; Shu-Yuan Liao; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2012-09-10       Impact factor: 3.090

8.  High prevalence of extended-spectrum β-lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India.

Authors:  Ashish Pathak; Yogyata Marothi; Vandana Kekre; Kalpana Mahadik; Ragini Macaden; Cecilia Stålsby Lundborg
Journal:  Infect Drug Resist       Date:  2012-04-05       Impact factor: 4.003

9.  In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.

Authors:  Sheetal Chitnis; Gunjan Katara; Nanda Hemvani; Siddika Pareek; Dhananjay Sadashiv Chitnis
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

10.  Prognosis of patients with methicillin-resistant Staphylococcus aureus bloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations.

Authors:  Jann-Tay Wang; Hau-Shin Wu; Chia-Min Weng; Le-Yin Hsu; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2013-04-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.